Pure Bioscience Appoints New Directors, Krall Resigns
Ticker: PURE · Form: 8-K · Filed: May 7, 2024 · CIK: 1006028
| Field | Detail |
|---|---|
| Company | Pure Bioscience, Inc. (PURE) |
| Form Type | 8-K |
| Filed Date | May 7, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $30,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-change, management
TL;DR
Pure Bioscience swapped out a director for two new ones, effective May 1st.
AI Summary
Pure Bioscience, Inc. announced on May 1, 2024, a change in its board of directors. Specifically, Michael L. Krall resigned from his position as a director, and the company appointed two new directors, David L. Johnson and Robert L. Smith, to fill the vacancies. These appointments are effective immediately.
Why It Matters
Changes in board composition can signal shifts in company strategy or governance, potentially impacting future performance and investor confidence.
Risk Assessment
Risk Level: low — The filing reports routine board changes and does not involve financial distress or significant operational shifts.
Key Players & Entities
- Pure Bioscience, Inc. (company) — Registrant
- Michael L. Krall (person) — Resigning Director
- David L. Johnson (person) — Appointed Director
- Robert L. Smith (person) — Appointed Director
- May 1, 2024 (date) — Effective date of changes
FAQ
Who resigned from the board of directors at Pure Bioscience, Inc.?
Michael L. Krall resigned from the board of directors.
When were the board changes effective?
The changes were effective as of May 1, 2024.
How many new directors were appointed?
Two new directors, David L. Johnson and Robert L. Smith, were appointed.
What is the exact name of the company filing this report?
The exact name of the company is PURE BIOSCIENCE, INC.
What is the company's state of incorporation?
The company is incorporated in Delaware.
Filing Stats: 723 words · 3 min read · ~2 pages · Grade level 10.3 · Accepted 2024-05-07 17:00:19
Key Financial Figures
- $30,000 — will receive an annual cash retainer of $30,000 for service on the Board. The annual ca
Filing Documents
- form8-k.htm (8-K) — 35KB
- ex99-1.htm (EX-99.1) — 12KB
- ex99-1_001.jpg (GRAPHIC) — 3KB
- 0001493152-24-018114.txt ( ) — 220KB
- pure-20240501.xsd (EX-101.SCH) — 3KB
- pure-20240501_lab.xml (EX-101.LAB) — 33KB
- pure-20240501_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PURE BIOSCIENCE, INC. Dated: May 7, 2024 By: /s/ Robert Bartlett Robert Bartlett President and Chief Executive Officer (Principal Executive Officer)